浏览全部资源
扫码关注微信
1.山东中医药大学药学院,济南 250355
2.山东省中医药研究院,济南 250014
硕士研究生。研究方向:中药药理学。电话:0531-82949847。E-mail:zhangru793@163.com
研究员,硕士生导师。研究方向:中药药理学。电话:0531-82949825。E-mail:wangpingjinan@126.com
纸质出版日期:2023-12-30,
收稿日期:2023-04-18,
修回日期:2023-11-21,
扫 描 看 全 文
张茹,杜海涛,王晓雪等.达原饮对RSV寒湿郁肺证小鼠肺部损伤和肠道菌群的影响 Δ[J].中国药房,2023,34(24):3000-3005.
ZHANG Ru,DU Haitao,WANG Xiaoxue,et al.Effects of Dayuanyin decoction on lung injury and gut microbiota in mice with RSV-Hanshi yufei syndrome[J].ZHONGGUO YAOFANG,2023,34(24):3000-3005.
张茹,杜海涛,王晓雪等.达原饮对RSV寒湿郁肺证小鼠肺部损伤和肠道菌群的影响 Δ[J].中国药房,2023,34(24):3000-3005. DOI: 10.6039/j.issn.1001-0408.2023.24.08.
ZHANG Ru,DU Haitao,WANG Xiaoxue,et al.Effects of Dayuanyin decoction on lung injury and gut microbiota in mice with RSV-Hanshi yufei syndrome[J].ZHONGGUO YAOFANG,2023,34(24):3000-3005. DOI: 10.6039/j.issn.1001-0408.2023.24.08.
目的
2
探讨达原饮对RSV寒湿郁肺证小鼠肺部损伤和肠道菌群的影响。
方法
2
将36只BALB/c小鼠分为正常组(NC组)、模型组(MC组)、阳性对照组(LBM组,利巴韦林57.59 mg/kg)和达原饮低、中、高剂量组(LDYY、MDYY、HDYY组,达原饮按生药量计1.67、3.34、6.68 g/kg),每组6只。除NC组外,其余各组小鼠采用“寒湿造模+RSV感染”的方式建立RSV寒湿郁肺证小鼠模型;于第2次寒湿刺激结束后,鼻腔滴注50倍半数细胞培养物感染量的RSV液,每天1次,连续3 d;各药物组于每次滴鼻4 h后灌胃相应药液,每天1次,连续5 d。检测小鼠血清中胃动素(MTL)、胃泌素(GAS)水平,肺组织上清液中白细胞介素6(IL-6)、IL-1β水平,外周血淋巴细胞百分比;观察肺组织病理形态变化并分析肠道菌群变化。
结果
2
与MC组比较,达原饮各组小鼠血清中MTL水平(HDYY组除外)和肺组织上清液中IL-6、IL-1β水平均显著降低,血清中GAS水平(HDYY组除外)均显著升高(
P
<0.05或
P
<0.01),肺组织病理状态均改善;LDYY组外周血中T淋巴细胞的百分比和MDYY组外周血中T、B淋巴细胞的百分比均显著升高(
P
<0.05或
P
<0.01)。与NC组比较,MC组中拟杆菌门、放线菌门、拟杆菌属、另枝菌属
、
拟杆菌纲、产酸拟杆菌、拟普雷沃氏菌属等呈高丰度表达,厚壁菌门、变形菌门、毛螺菌属NK4A136组、丝状菌属、未分类的
Clostridiales
等呈低丰度表达;经中剂量达原饮干预后,各菌群相对丰度均有回调趋势,其差异物种包括
Lachnospiraceae_UCG-006
、瘤胃球菌属
Ruminococcus
等。
结论
2
达原饮能够减轻RSV寒湿郁肺证小鼠的肺部损伤,其机制可能与减轻炎症、调节胃肠激素水平和淋巴细胞百分比以及肠道有益菌和有害菌的相对丰度有关。
OBJECTIVE
2
To study the effects of Dayuanyin decoction (DYY) on lung injury and gut microbiota in mice with RSV-Hanshi yufei syndrome.
METHODS
2
Thirty-six BALB/c mice were divided into the normal group (NC group), model group (MC group), positive control group (LBM group, 57.59 mg/kg ribavirin), DYY low-dose, medium-dose and high-dose groups(LDYY,MDYY,HDYY groups,1.67,3.34,6.68 g/kg,calculated by crude drug), with 6 mice in each group. Except for NC group, RSV-Hanshi yufei syndrome model was induced by “Hanshi modeling+RSV infection”; after the second cold and wet stimulation, RSV solution was dripped into the nasal cavity at 50% tissue culture infectious dose, once a day, for 3 consecutive days; each administration group was given corresponding solution intragastrically 4 hours after each nasal drip, once a day, for 5 consecutive days. The levels of motilin (MTL) and gastrin (GAS) in serum, the levels of IL-6 and IL-1β in supernatant of lung tissue, and the percentage of peripheral blood lymphocytes were all determined. The pathological changes of lungs were observed, and the changes of gut microbiota were analyzed.
RESULTS
2
Compared with MC group, the levels of MTL in serum (except for HDYY group), and the levels of IL-6 and IL-1β in supernatant of lung tissue were all decreased significantly in DYY groups, while the level of GAS (except for HDYY group) in serum was increased significantly (
P
<0.05 or
P
<0.01). The pathology of lung tissue was improved, the percentage of T lymphocytes in LDYY group and the percentages of T lymphocyte and B lymphocyte in MDYY group were all increased significantly (
P
<0.05 or
P
<0.01). Compared with the NC group, Bacteroidetes, Actinobacteria,
Bacteroides
,
Alistipes
, Bacteroidota,
Bacteroides acidfaciens
and
Alloprevotella
were expressed in high abundance, while Firmicutes, Proteobacteria,
Lachnospiraceae
NK4A136 group,
Kineothrix
and
Clostridiales
unclassified were expressed in low abundance. After the intervention of medium-dose DYY, the relative abundance of each microbiota tended to be adjusted back, with different species including
Lachnospiraceae
_
UCG
-
006
,
Ruminococcus
, etc.
CONCLUSIONS
2
Dayuanyin decoction can reduce the lung injury caused by RSV, the mechanism of which may be associated with relieving inflammation, regulating gastrointestinal hormone levels, the percentage of lymphocytes and the abundance of beneficial and harmful bacteria in the intestinal tract.
达原饮呼吸道合胞病毒寒湿郁肺证肠道菌群
respiratory syncytial virusHanshi yufei syndromegut microbiota
BONT L,CHECCHIA P A,FAUROUX B,et al. Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in Western countries[J]. Infect Dis Ther,2016,5(3):271-298.
李艳彦,李俊莲,马彦平,等. 不同外邪对小鼠呼吸道合胞病毒含量影响的实验研究[J]. 世界中西医结合杂志,2013,8(3):279-282.
LI Y Y,LI J L,MA Y P,et al. Experimental research of the impacts of different exogenous pathogens on the content of respiratory syncytial virus in mice[J]. World J Integr Tradit West Med,2013,8(3):279-282.
王静,吴倩,于丽秀,等. 达原饮抗新型冠状病毒肺炎的研究现状[J]. 中国临床药理学杂志,2021,37(4):466-468.
WANG J,WU Q,YU L X,et al. Research status of dayuanyin against corona virus disease 2019[J]. Chin J Clin Pharmacol,2021,37(4):466-468.
任慧玲,严彪,梁之桃,等. 达原饮解热作用研究及UPLC-Q-TOF/MS分析[J]. 中成药,2015,37(1):131-137.
REN H L,YAN B,LIANG Z T,et al. Antifebrile effect of Dayuanyin and its determination by UPLC/Q-TOF-MS[J]. Chin Tradit Pat Med,2015,37(1):131-137.
王建美,王冉冉,袁天翊,等. 达原饮通过NF-κB信号通路预防低氧性肺动脉高压作用及机制研究[J]. 药学学报,2023,58(4):928-937.
WANG J M,WANG R R,YUAN T Y,et al. The preventive effect and mechanism of Dayuanyin in hypoxic pulmonary hypertension through NF-κB signaling pathway[J]. Acta Pharm Sin,2023,58(4):928-937.
LIN L,JIANG X Y,ZHANG Z L,et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection[J]. Gut,2020,69(6):997-1001.
JI J J,SUN Q M,NIE D Y,et al. Probiotics protect against RSV infection by modulating the microbiota-alveolar-macrophage axis[J]. Acta Pharmacol Sin,2021,42(10):1630-1641.
LIANG Y Y,LI K W,NIU F J,et al. Salvia plebeia R. Br. polysaccharides(SPP)against RSV(respiratory syncytial virus)infection:antiviral effect and mechanisms of action[J]. Biomedecine Pharmacother,2021,141:111843.
张茹,王晓雪,杜海涛,等. 基于代谢组学研究经典名方达原饮对RSV寒湿郁肺证小鼠模型的作用机制[J/OL]. 中华中医药学刊:1-13[2023-09-10].https://kns.cnki.net/kcms/detail/21.1546.R.20230726.0846.002.htmlhttps://kns.cnki.net/kcms/detail/21.1546.R.20230726.0846.002.html.
ZHANG R,WANG X X,DU H T,et al.Mechanism of famous classical formula Dayuanyin decoction in treatment of mice model with RSV and Hanshi yufei syndrome based on metabonomics[J/OL]. Chin Arch Trad Chin Med:1-13[2023-09-10].https://kns.cnki.net/kcms/detail/21.1546.R.20230726.0846.002.htmlhttps://kns.cnki.net/kcms/detail/21.1546.R.20230726.0846.002.html.
何文娇,胡甜,石晶晶,等. 基于16S rDNA技术研究黄连解毒汤对db/db糖尿病小鼠肠道菌群的影响[J]. 中华中医药杂志,2021,36(8):5024-5028.
HE W J,HU T,SHI J J,et al. Effects of Huanglian Jiedu Decoction on gut microbiota in db/db mice based on 16S rDNA sequencing technology[J]. China J Tradit Chin Med Pharm,2021,36(8):5024-5028.
SEGATA N,IZARD J,WALDRON L,et al. Metagenomic biomarker discovery and explanation[J]. Genome Biol, 2011,12(6):R60.
耿子涵,包蕾,郭姗姗,等. 人冠状病毒229E寒湿疫毒袭肺证病证结合小鼠模型的建立及评价[J]. 中国比较医学杂志,2022,32(1):3-12,67.
GENG Z H,BAO L,GUO S S,et al. Establishment and evaluation on a mouse model combing disease with syndrome of hCoV-229E pneumonia with “Hanshi Yidu Xifei” syndrome[J]. Chin J Comp Med,2022,32(1):3-12,67.
HOOPER L V,LITTMAN D R,MACPHERSON A J. Interactions between the microbiota and the immune system[J]. Science,2012,336(6086):1268-1273.
黄树武,闵凡贵,王静,等.常用小鼠、大鼠肠道菌群比较研究[J].中国实验动物学报,2021,29(6):777-784.
HUANG S W,MIN F G,WANG J,et al.Comparative study of intestinal flora in common mice and rats[J]. Acta Lab Animalis Sci Sin,2021,29(6):777-784.
GROVES H T,CUTHBERTSON L,JAMES P,et al. Respiratory disease following viral lung infection alters the murine gut microbiota[J]. Front Immunol,2018,9:182.
DE VOS W M,TILG H,VAN HUL M,et al.Gut micro-biome and health:mechanistic insights[J]. Gut,2022,71(5):1020-1032.
RODUIT C,FREI R,FERSTL R,et al. High levels of butyrate and propionate in early life are associated with protection against atopy[J]. Allergy,2019,74(4):799-809.
JIANG Q L,XU Q,KENÉZ Á,et al. Klebsiella pneumoniae infection is associated with alterations in the gut microbiome and lung metabolome[J]. Microbiol Res,2022,263:127139.
YAO Y,FENG S Y,LI X J,et al. Litchi procyanidins inhibit colon cancer proliferation and metastasis by trigge-ring gut-lung axis immunotherapy[J]. Cell Death Dis,2023,14(2):109.
CHEN S,GUI R,ZHOU X H,et al. Combined micro-biome and metabolome analysis reveals a novel interplay between intestinal flora and serum metabolites in lung cancer[J]. Front Cell Infect Microbiol,2022,12:885093.
0
浏览量
2
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构